MEDIF
MediPharm Labs Corp.·Healthcare
0.05
0.629%(+0.00)
Close PriceLast Updated: — ET
52W L: $0.0452W H: $0.08
MEDIF NEWS
seekingalpha.com
Mar 30
MediPharm Labs Corp. (LABS:CA) Q4 2025 Earnings Call Transcript
MediPharm Labs Corp. (LABS:CA) Q4 2025 Earnings Call Transcript
globenewswire.com
Mar 30
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
FY 2025 revenue of $45.1 million, an increase of 8% over 2024 International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenue Increased cash balance of $10.8 Million at the end of Q4, up $0.2 million from Q3 2025 Company remains virtually debt-free, with outright ownership of two production facilities Management to Host Conference Call / Webcast on March 30th, 2026, at 10:00 am ET TORONTO, March 30, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the full year and three months ended December 31, 2025. MediPharm achieved 8% annual revenue growth in 2025, driven by the continued execution of its international medical cannabis strategy.
globenewswire.com
Mar 25
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results
MediPharm Labs will release its financial results for the three & twelve months ended December 31st, 2025, before markets open on Monday, March 30th, 2026.
globenewswire.com
Jan 19
MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced that David Pidduck will be stepping down from his role as the Company's Chief Executive Officer, effective January 23rd, 2026. The Board of Directors (the "Board") has appointed Greg Hunter, the Company's Chief Financial Officer, as Interim Chief Executive Officer, while it evaluates its long‑term leadership plans.
